Tumor samples are conserved in clinical practice in formalin-fixed paraffin-embedded (FFPE) blocks. Formalin fixation chemically alters nucleic acids, rendering transcriptomic analysis challenging. RNA-sequencing is usually performed on tumor bulk, without distinction of cell subtypes or location. Here we describe the development of a robust method for RNA extraction and exome-capture RNA-sequencing of lasercapture microdissected tumor cells (TC) and stromal immune cells (TIL) based on their morphology. We applied this method on 7 tumor samples (surgical or core needle biopsy) of triple-negative breast cancer (TNBC) stored in FFPE blocks over 3-10 years.
Introduction
Solid tumors are composed of cancer cells and non-cancer cells such as immune cells, fibroblasts and endothelial cells (1, 2) that vary in proportions and state from one tumor to another. These cells compose the tumor microenvironment (TME) and can have a tumor-promoting or tumor-suppressive role (3) . For instance, stromal tumor-infiltrating lymphocytes (TIL) are associated with good prognosis in patients with triple-negative breast cancers (TNBC) and predict response to chemotherapy (4) whereas cancerassociated fibroblasts have a deleterious effect (5) .
Bulk RNA-sequencing is an accessible method for studying tumor transcriptome.
Although it might be possible to algorithmically deconvolute the abundance of TME components from bulk data (6, 7) , this analysis cannot resolve fine details such as the activation state of immune cells and is challenging to validate experimentally. In addition, the spatial relationship of tumor components, for instance tumor-infiltrating versus tumor-excluded lymphocytes, is obvious under microscopy, but cannot be inferred from bulk data. Single-cell RNA sequencing is a powerful method to investigate cell-to-cell variability and discover biologically relevant cell subtypes but it has been limited so far to the analysis of fresh/frozen tissues and does not permit spatial characterization of TME. Importantly, single-cell RNA-sequencing cannot easily recapitulate the complexity of an heterogeneous tumor from a few thousand cells and has not been proven to accurately capture cell proportions, possibly overestimating the abundance of some cell types such as immune cells (8) .
Laser capture microdissection (LCM) is a technique that allows to collect separately distinct cell populations under direct microscopic visualization. One of the advantages of LCM is that specific cell subtypes can be recognized based on their morphology on hematoxylin or immunohistochemically-stained tissue sections (9) . The selected cells are cut from tissue section using a laser beam and collected separately from the rest of the section. This approach provides a pool of cells enriched for a cell subtype of interest, from which RNA can be extracted for sequencing. An important advantage of LCM is that it enables the reuse of clinical material, which is usually formalin-fixed paraffin-embedded (FFPE) for diagnostic purposes. Formalin fixation allows better preservation of tissue morphology but leads to cross-linking and fragmentation of nucleic acids, making downstream sequencing more challenging (10) . To overcome the challenges of working with RNA from FFPE samples, we optimized multiple steps of LCM and RNA extraction processes. We demonstrated the feasibility of performing RNA-sequencing from laser-capture microdissected stromal TIL and tumor cells from FFPE samples of TNBC (Figure 1 ). Here, we performed an exome-capture RNAsequencing method that captures the coding regions of fragmented RNA. We validated this approach by qRT-PCR on a selected list of genes and by multispectral immunohistochemistry. Overall, we propose a method that renders feasible spatial transcriptomic analyses of TME in FFPE tumor samples.
Results

Optimization of laser capture microdissection
Formalin fixation induces chemical cross-linking and RNA fragmentation, rendering subsequent genomic and transcriptomic analysis of FFPE material challenging. Thus, we optimized the tissue preparation process before LCM in order to maximize RNA yield while preserving RNA quality. The standard protocol for hematoxylin and eosin (H&E) staining used in clinical pathology lasts 27 min. However, prolonged immersion of tissue sections in clearing agent such as xylene further degrades nucleic acids (11) . Therefore, we tested three different dyes (hematoxylin, eosin and crystal violet) and varying durations of incubation (supplementary Table 1 and supplementary Figure   1A ). We aimed to shorten the duration of staining procedure while conserving maximal contrast in order to distinguish cell subtypes based on their morphology. Adding crystal violet dye or Scott's tap water to the staining process led to low contrast images. The optimal staining was obtained with protocol b (supplementary Table 1 ) that had shorter duration of staining (15 min) and renders good contrast (supplementary Figure 1A) .
Second, we determined the maximal tissue section thickness that allows the collection of a maximum number of cells and adequate visualization of cells' morphology. Tissue sections of 6 and 8 µm thickness showed similar cell morphologies compared to the standard H&E tissue section of 3 μm whereas tissue section of 10 µm had too many "compacted" cells causing reduced contrast between tumor cells (TC), cancerassociated fibroblasts (Fib) and tumor-infiltrating lymphocytes (TIL) (supplementary Figure 1B) . Therefore, we chose 8 µm as the optimal thickness for subsequent experiments.
Third, we aimed to determine the optimal surface of area to microdissect. A typical human cell contains 10-30 pg of RNA (12) . However, the number of cells per surface varies according to tissue density. We estimated the number of cells to 7'000 per mm 2 in TNBC sample. Accordingly, the quantity of RNA that would be theorically extracted was estimated to vary between 70 and 210 ng/mm 2 . We set up the minimal surface to be microdissected to 2.5 mm 2 from 8 µm thick tissue sections of a one-year-old FFPE block which corresponds to an expected amount of 172-500 ng of RNA Figure 2) .
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Optimization of RNA extraction
We sought to optimize the RNA extraction procedure from microdissected area of 2.5 mm 2 with the objective of collecting RNA of the best possible quality and quantity.
Minimal requirements for exome-capture RNA-sequencing with the TruSeq® protocol are: a) RNA integrity number (RIN) > 1.4, b) the percentage of fragments over 200 nucleotides (DV200) > 30% and c) a minimum yield of 40 ng depending on RNA quality (13). Following the RNeasy FFPE Qiagen® kit's protocol (supplementary Figure 3A) , RNA yield was undetectable using an elution volume of 30 µl for a tissue section surface of 2.5 mm 2 . Thus, we tested several modifications of the protocol in order to optimize RNA yield and quality. First, the eluted volume was reduced to 15 µl and mechanical digestion by stirring (400 rpm) was added, and subsequently concentrated using a vaccum concentrator centrifuge to a final volume of 4 µl. This rendered RNA detectable (yield 18-40 ng). Second, we increased the duration of enzymatic digestion.
The original RNeasy protocol recommends tissue digestion for 15 min at 56 °C with proteinase K. We tested four different durations of digestion with proteinase K (15 min, 1h, 3h and overnight). RNA yield tended to increase with prolonged digestion, whereas DV200 initially reached a maximum at 3h but declined after overnight digestion. RIN was not affected by the duration of tissue digestion (supplementary Figure 3B-D) .
Thus, 3h was set as the optimal duration of digestion to collect RNA with sufficient quality and quantity. These modifications led to the final protocol (supplementary Figure 3E ) that was tested on seven FFPE samples of TNBC aged from 3 to 10 years. Sufficient RNA from microdissected TIL and TC was collected from either core needle biopsies (n=2) or surgical biopsies (n=5) for subsequent sequencing (Supplementary Table 2 ). Extracting RNA from microdissecting Fib was more challenging: sufficient RNA yield was collected from only two out of seven tumors (supplementary Figure   3F ). The age of the block did not impact RNA yield or RIN (supplementary Figure   3G -H) but we noticed a decrease of DV200 in older blocks (supplementary Figure 3I) .
Library preparation and exome-capture RNA sequencing
The library was prepared with the TruSeq® protocol on 16 samples: 7 TIL, 7 TC and 2 Table 2 ). Exome-capture RNA sequencing was performed in multiplex, yielding an average of 49.3 M paired-end stranded reads. All samples passed the per base and per sequence quality score criteria (mean Phred quality score≥39) of the FastQC tool ( Supplementary Table 3 ). On average, 76% of reads successfully aligned with the reference transcriptome (GRCh38 cDNA) using Salmon.
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Exploratory data analysis
Transcript abundance was estimated with Salmon and summarized at the gene level using the "tximport" tool from the DEseq2 package. The Principal Component Analysis (PCA) clearly separated TC, TIL and Fib. Technical replicates (same sample run in two different lanes) were in good agreement ( Supplementary Figure 4) and were subsequently merged for better visualization (Figure 3A) . These results suggest that TC samples are more similar to each other than they are to TIL and Fib. The same holds true for TIL and Fib samples. The PCA showed that the two Fib samples were placed closed to the TIL on the primary PCA axis, indicating a higher similarity among the Fib and TIL at the gene expression level ( Figure 3A) . The two Fib samples were excluded from further transcriptomic analyses. The distribution of TC and TILs samples according to the PCA was in agreement with the dendrogram and the heatmap generated based on correlation distances between samples ( Figure 3B ). 
Transcriptomic characterization of TC and TIL
Differential expression analysis
We performed differential expression analysis (DEA) comparing TC and TIL. In total, we identified 1776 genes that were differentially expressed between TC and TIL: 1003 genes were upregulated in TIL while 773 genes were upregulated in TC (Supplementary Tables 4 and 5). We observed that several genes such as MUC1, TFAP2A, MAL2 and ELF3 already reported to be expressed in breast cancer (14) (15) (16) and particularly TNBC (17) , were among the most significantly highly expressed genes in microdissected TC compared to TIL (Supplementary table 4) . In addition, TC expressed several epithelial markers like EPCAM, KRT8, KRT18 and KRT19. Among top upregulated genes in TIL, there were several genes known to be B cells-related (CD79A, CD79B, PAX5, BLNK, and MS4A1) and T cells-related genes (CD2, CD3D, CD3E, CD3G, and CD8B) ( Supplementary table 5 ).
T cell co-signaling (co-stimulatory and co-inhibitory) receptors are cell-surface molecules that have a crucial role in regulating T cell function toward effector or suppression (18) . We found that most of T cells co-stimulation markers such as CD27, CD28 and SLAMF1 and several co-inhibition markers/immune checkpoint inhibitors like CTLA4 and TIGIT were substantially increased in microdissected TIL (Figure 4A and B) (19) . PD-L1 (CD274) was numerically higher in TIL but the difference was not significant (p=0.39). Among immune checkpoint inhibitors, CD160 and BTLA are both ligands for the same receptor HVEM (TNFRSF14): we found that BTLA (p=1.36x10 -4 ) was significantly upregulated in TIL but not CD160 (Figure 4B ), suggesting that within the context of TNBC BTLA could be more involved in tumor immunosuppression.
Validation by quantitative RT-PCR of selected genes
We used quantitative RT-PCR (qRT-PCR) to confirm gene expression of randomly selected genes among the most significantly upregulated in TC versus TIL and TIL vs TC. Ten genes were evaluated: five genes upregulated in TIL (CD28, CCR7, CD79B, FCMR and PAX5) and five genes upregulated in TC (ELF3, MAL2, MUC1, TFAP2A and GPR37). Overall, qRT-PCR ( Figure 5B ) results mirrored the RNA-sequencing data ( Figure 5A) .
Abundance of immune cell subpopulations
Deconvolution of bulk-RNAseq data was performed using microenvironment cell population (MCP)-counter method in order to estimate the abundance of different immune cell subpopulations (6) . The analysis showed enrichment in adaptive immune cell signatures such as B cells and T cells in microdissected TIL, whereas innate immune cells signatures like neutrophils and monocytes were heteregenously present in TC and TIL ( Figure 6A ). Spatial enrichment in specific immune cell subpopulations was variable across the seven cases of TNBC. For instance, patient 73 (grey full arrows, Figure 6A ) had TC enriched in T cells signature, particularly CD8 + T and cytotoxic T cells. This was confirmed by multispectral immunohistochemistry (IHC) that showed massive intraepithelial accumulation of CD8 + cells (Figure 6B ). This case would be classified as "fully-inflamed" (20) . On the opposite, patient 69 (black full arrow, Figure 6A ) had low T cells and CD8 + T cells scores in TC but not in TIL.
Multispectral IHC confirmed the absence of intraepithelial CD8 + cells (Figure 6B and Supplementary Figure 5A) , that were rather present at tumor margins (Supplementary Figure 5B) . Thus, both MCP-counter and IHC suggest that patient 69 has CD8 + T cells that are not located on the tumor core but rather at tumor margin, designated as "margin restricted" (20) . High spatial variability was also observed in the monocytic lineage. Monocytic lineage score was high among microdissected TC in patient 65 (grey empty arrow, Figure 6A ) and low in patient 88 (black empty arrow, Figure 6A ). Multispectral IHC confirmed the accumulation of intraepithelial CD68 + cells in patient 65, whereas they were mainly in the stromal compartment surrounding TC in patient 88 ( Figure 6B) . Overall, these data validated the combination of LCM and MCP-counter deconvulation as an approach for spatial characterization of immune infiltrate in TME. 
Methods
Samples and inclusion criteria
Estimation of number of cells per area
An H&E section of TNBC was scanned into MRXS image and quantified with QuPath (version 0.1.2, open source software). The polygon and point tools were used to count the nuclei within surface areas varying between 0.03-0.5 mm 2 . A linear regression of these values was used to estimate the number of cell for larger area of 1-2.5 mm 2 .
Estimation of the quantity of RNA was calculated by multiplying the estimated number of cells to the estimated amount of RNA within a cell (10-30 pg/cell) (12) .
Workflow of FFPE laser capture microdissection and RNA -sequencing
To study spatial transcriptomics of TME on FFPE samples of TNBC, we performed LCM of 3 different cell subtypes (TC, TIL and Fib) followed by RNA extraction, library preparation and exome-capture RNA-sequencing (Figure 1) . LCM procedure consisted in the manual delimitation of TC, stromal TIL (tumor core and margins) and
Fib under direct microscopic visualization (step 1). Cells of interest were selected using a drawing tool on the Leica Laser Microdissection software. Selected regions of interest were cut from tumor sections with a laser beam. Microdissected samples were collected within the cap of a PCR tube placed under the polyethylene terephthalate membrane (PET) slide; the corresponding total RNA was extracted (step 2), followed by library preparation, which included the conversion of RNA into cDNA fragments and the addition of adaptors (step 3). Libraries were subjected to sequencing (step 4). 
Laser capture microdissection
RNA extraction, quantification and fragment size analysis
Data processing
Quality control was performed on raw sequencing data using the FastQC tool (21) . were used to identify differentially expressed genes between tumor cells (TC) and TIL samples.
Functional analysis
In order to characterize variations in biological pathways in TC and TIL, GSVA was performed (32) . For this purpose, KEGG, Biocarta and Reactome gene sets from the C2 collection of the MSigDB v6.2 (c2BroadSets) were used (33, 34) . GSVA analysis was performed on the variance stabilized expression value matrix of 1776 differentially expressed genes (adjusted p-value<0.05 and FoldChange ≥ 1.5, i.e. log2FC>0.58).
Limma (35) was used for the generalized linear model fitting on the GSVA output in order to identify enriched pathways between TC and TIL. The Benjamini-Hochberg (BH) adjustment for FDR was applied. Significant pathways were identified with the adjusted p-value cutoff<0.05 and absolute log fold change cutoff for the enrichment score (log2FC > 0.58).
MCP-counter analysis
MCP-counter method (6) provides unified access to several other deconvolution methods (36) .
Real-time quantitative PCR
Selected marker genes were validated using qRT-PCR. Sybr green assays were designed with Primer3 (version 4.1.0) with default parameters. Amplicon sequences were aligned against the human genome by BLAST to ensure the specificity of the primers for the genes of interest. The oligonucleotides sequences are listed in Supplementary Table 6 . Oligonucleotide (Invitrogen, Thermofisher Scientific) sequences can be obtained upon request for the human TFRC and ALAS1 genes. 
Data availability
Upon publication, RNA-sequencing data will be available in raw FASTQ format from the Array Express database. The array express accession number is E-MTAB-8760.
Discussion
We developed a new, robust method for spatial transcriptomic characterization of tumor microenvironment on FFPE samples. Unlike bulk RNA-sequencing on fresh tissue or single-cell RNA-sequencing, in which RNA is extracted without visualization of the tissue context, LCM focuses on specific regions or cells of interest. Here, we successfully applied this method to TNBC samples, the most aggressive subtype of breast cancer (38) , characterized by the presence of TIL mainly in the stromal compartment with prognostic and predictive value (39, 40) .
RNA is most often extracted from fresh frozen tissue. In most studies using laser microdissection, library preparation was performed on fresh frozen tissue (41, 42) access to tumor samples is limited to core needle biopsies (44, 45) . The blocks we used were 3 to 10 years old and are representative of the material available in a clinical pathology biobank.
The most common protocol for RNA sequencing consists of enrichment of messenger RNA (mRNA) by poly(A) selection, which targets the polyadenylated RNA tail (46) .
However, poly(A) selection does not perform well when mRNA is degraded, because the poly(A) tail can be lost. The exome-capture protocol performs better than ribosomal RNA depletion on highly degraded and small amounts of RNA (47) . Exome-capture on RNA extracted from FFPE showed minimal differences when compared with matched fresh-frozen samples (46, 48) and seemed the most appropriate approach for our method.
We applied spatial transcriptomics to either core needle or surgical biopsies of 7 FFPE samples of TNBC. PCA showed a clear separation between TIL, cancer cells and fibroblasts. This was further confirmed by per-sample GSVA analyses. Differential expression analyses showed that MUC1 was among the most significantly upregulated gene in TC. MUC1 (CA15-3) is a well-characterized transmembrane mucin previously reported to be upregulated by 90% of TNBC (17) and it is FDA-approved serum tumor marker for monitoring metastatic breast cancer patients. Overxpression of MUC1
validates the accuracy of gene-expression profile of microdissected TC. A similar approach could be used for identifying new biomarkers for diagnosis and prediction of response to therapy.
We questioned the abundance of different immune cell types from the expression profile with MCP-counter deconvolution (6), a well-established method that has been used to identify predictive biomarkers for response to immunotherapy (44) . Spatial enrichment in specific immune cell subpopulations was variable across the seven cases of TNBC as confirmed by multispectral IHC. Stroma TIL were enriched in B and T cell signatures whereas myeloid and monocytic lineage signatures were heterogeneously enriched in TIL and TC. Here we propose that combining LCM and MCP-counter could be an alternative approach to multispectral IHC.
The repertoire of co-signalling receptors expressed on T cells is highly versatile and responsive to changes in the tissue microenvironment (18) . An exploratory analysis of the spatial distribution of co-signaling receptors revealed that T cells co-inhibitory molecules/immune checkpoint inhibitors BTLA but not CD160 was significantly upregulated in stromal TIL. Since BTLA and CD160 are both ligands of the same receptor HVEM (18), BTLA but not CD160, could facilitate immune evasion in the context of TNBC and hence represents a potential therapeutical target. Our approach of spatial characterization of co-signaling receptors through parallel analyses of the receptors and their ligands could bring new information on the cross-talk between components of TME.
Overall, our method allowed the concomitant analysis of : 1) the abundance of immune cell types; 2) the expression levels of co-signaling molecules in different TME compartments and 3) the enrichment of specific genes/pathways in cancer cells. Thes informations cannot be obtained by alternative solutions like nanostring® or multispectral IHC. It has potential applications beyond immuno-oncology and could be used in any FFPE tissue without predefining cell lineage-specific markers.
The method we developed has several limitations. Although fibroblasts represent a substantial proportion of the total surface of TNBC (5), we were able to collect sufficient RNA from microdissected fibroblasts in only 2 out of 7 TNBC cases. Fibroblasts are embedded within the extracellular matrix and are particularly difficult to isolate. A recent technical report on single-cell RNA sequencing showed that extended collagenase incubation time is required to release fibroblasts from tissue samples whereas nonadherent cells such as immune cells are readily and rapidly isolated by enzymatic disaggregation (49) . It would be important to test whether adding digestion with collagenase could increase RNA yield of microdissected fibroblasts. Another limitation is intraepithelial TIL (patient 73 in our cohort) which are more difficult to microdissect than stromal TIL. To overcome this challenge, an alternative could be combining LCM with either single-cell RNA-sequencing (50) or IHC staining as we previously described for DNA whole-exome sequencing (9) .
Conclusion
In summary, we demonstrate the feasibility of using FFPE blocks of various ages to investigate the spatial transcriptomic profile of TME in TNBC. Optimization of LCM and 
